Various parameters representing gene and chromosome copy numbers were evaluated for association with pCR in an effort to identify parameters most effective for improving prediction in the neoadjuvant treatment of ERBB2-positive breast cancer. This evidence concerns the gene ERBB2 and breast cancer.